PureTech Health plc is developing medicines for intractable cancers, as well as inflammatory, fibrotic and immunological, lymphatic and gastrointestinal, and neurological and neuropsychological diseases in the U.S. KarXT (to treat schizophrenia and psychosis in Alzheimer's disease) is currently in-market. Under development are a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions, an immunomodulation platform to treat chronic and acute inflammatory disorders, and oral therapies based on defined consortia of bacteria is isolated from the human microbiome. Puretech Health was incorporated in 2015 and is headquartered in Boston, MA.
What is Puretech Health's quote symbol?
What is the 52 week high and low for Puretech Health (NASDAQ: PRTC)?
How much is Puretech Health stock worth today?
How much is Puretech Health's stock price per share?
What is Puretech Health's Market Cap?